Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
VRNA
Stock Latest News
Press Releases
Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update
2d ago
VRNA
Premium
The Fly
Verona Pharma price target raised to $37 from $35 at Canaccord
5d ago
VRNA
Premium
The Fly
Verona Pharma call volume above normal and directionally bullish
9d ago
VRNA
Premium
The Fly
Verona Pharma call volume above normal and directionally bullish
10d ago
VRNA
Premium
The Fly
Verona Pharma call volume above normal and directionally bullish
16d ago
VRNA
Premium
The Fly
Verona Pharma price target raised to $38 from $32 at Truist
29d ago
VRNA
Premium
The Fly
Unusually active option classes on open June 27th
30d ago
IP
NU
Premium
The Fly
Verona approval label may benefit Regeneron, says RBC Capital
30d ago
REGN
VRNA
Premium
The Fly
Ligand earns $5.8M milestone payment following FDA approval of Ohtuvayre
30d ago
LGND
VRNA
Premium
Company Announcements
Verona Pharma’s FDA Approval for New COPD Treatment
30d ago
8K
VRNA
Premium
The Fly
Verona Pharma price target raised to $36 from $32 at H.C. Wainwright
30d ago
VRNA
Premium
The Fly
Verona Pharma trading resumes
1M ago
VRNA
Premium
Press Releases
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
1M ago
VRNA
Premium
The Fly
Verona Pharma announces FDA approval of Ohtuvayre
1M ago
VRNA
Premium
The Fly
Verona Pharma trading halted, news pending
1M ago
VRNA
Premium
The Fly
Expert likely to prescribe more ensifentrine than dupixent, says Jefferies
2M ago
VRNA
Premium
The Fly
Jefferies healthcare analyst holds an analyst/industry conference call
2M ago
AZN
GSK
Premium
The Fly
Verona Pharma announces $650M strategic financing with Oaktree, OMERS
3M ago
HTGC
VRNA
Premium
The Fly
Verona Pharma reports Q1 EPS (4c), consensus (16c)
3M ago
VRNA
Premium
Company Announcements
Verona Pharma Plc Secures Funding and Negotiates Sales Milestones
3M ago
8K
VRNA
Premium
Press Releases
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
3M ago
VRNA
Premium
Press Releases
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
3M ago
VRNA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
